PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies
Abstract
Data di Pubblicazione:
2012
Citazione:
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies / Masselli, E; Mecucci, C; Gobbi, G; Carubbi, C; Bonomini, S; Prezioso, L; Rossetti, E; Caramatti, C; Vitale, M; Aversa, F.. - In: BLOOD. - ISSN 0006-4971. - 120:21(2012), pp. 2858-2858. ( 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)).
Tipologia CRIS:
4.2 Abstract in Atti di convegno
Elenco autori:
Masselli, E; Mecucci, C; Gobbi, G; Carubbi, C; Bonomini, S; Prezioso, L; Rossetti, E; Caramatti, C; Vitale, M; Aversa, F.
Link alla scheda completa:
Titolo del libro:
54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)
Pubblicato in: